Subutex Alternatives Compared
Subutex (buprenorphine) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
---|
Subutex (buprenorphine) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Subutex was a brand name of sublingual buprenorphine, but it has been discontinued. [Suboxone](https://www.drugs.com/suboxone.html), which contains buprenorphine and naloxone, may be used instead... View more |
Prescription only
Suboxone is a combination medicine containing buprenorphine and naloxone that is used to treat adults addicted to opioid medications. It should be used in conjunction with a complete treatment... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Related suggestions Opioid Use Disorder
|
|||||||||||||||
More about Subutex (buprenorphine) | More about Suboxone (buprenorphine / naloxone) | More about Buprenorphine / naloxone | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Subutex has an average rating of 8.6 out of 10 from a total of 144 ratings on Drugs.com. 84% of reviewers reported a positive effect, while 6% reported a negative effect. |
Suboxone has an average rating of 8.6 out of 10 from a total of 723 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 7% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.8 out of 10 from a total of 1124 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
None |
||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Suboxone prices |
View all Buprenorphine / naloxone prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans, Sublocade | Other buprenorphine / naloxone brands include: Zubsolv | Suboxone, Zubsolv | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
48 hours |
37 hours |
37 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 695 drugs are known to interact with Subutex:
|
A total of 700 drugs are known to interact with Suboxone:
|
A total of 700 drugs are known to interact with Buprenorphine / naloxone:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
October 08, 2002 |
October 08, 2002 |
October 08, 2002 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.